Paediatric

Paediatric - most related articles:

- New drug development program for children with HIV AIDS - 4.3
- Bipolar symptoms and emotional brain in youth - 3.8
- GSK statement on MHRA Seroxat investigation - 3.2
- Whooping cough booster for parents of newborns - 2.9

Paediatric articles

New drug development program for children with HIV AIDS
The Drugs for Neglected Diseases initiative (DNDi) announced the launch of a new drug development programme to address critical unmet treatment needs of children with HIV/AIDS. Because HIV transmission in young children has largely been eliminated in high-income countries due to effective prevention of mother-to-child transmission (PMTCT) interventions, little market incentive exists for pharmaceutical companies to develop antiretroviral (ARV) drugs adapted for children.

GSK to fight HIV AIDS in Africa
GlaxoSmithKline's CEO Andrew Witty announced a series of new initiatives targeted at improving research, development, and access to HIV/AIDS medicines for children in Sub-Saharan Africa and supporting healthcare for people living with HIV and AIDS.

Advice for treatment of cough, colds in children under 6
Responding to guidance issued by the Medicines and Healthcare products Regulatory Agency (MHRA), advising that cough and cold treatments should not be used for children under 6 years of age, the Royal Pharmaceutical Society of Great Britain (RPSGB) has issued the following advice to parents.

Childhood obesity and child protection issue
When does severe childhood obesity become a child protection issue? This is just one of the ethical, medical and legal questions confronting doctors as they deal with increasing rates of childhood obesity, according to a series of articles in the latest Medical Journal of Australia.

Whooping cough booster for parents of newborns
A booster vaccination for parents of new babies and other household members may be the most effective way of preventing the fatal form of whooping cough in young infants, say a group of paediatric intensive care doctors on bmj.com today.

GSK statement on MHRA Seroxat investigation
GlaxoSmithKline (GSK) notes the conclusions announced by the Medicines and Healthcare products Regulatory Agency (MHRA) regarding its investigation into disclosure of paediatric trial data for the anti-depressant medicine Seroxat (paroxetine).

6 Paediatric articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
1.28